Advertisement
Advertisement
SABS
SAB Biotherapeutics, Inc. Common Stock
3.07
USDSponsored
-0.03
-0.97%
Nov 10, 15:59 UTC -5
Closed
After-Market
3.07
0.00
0.00%
SAB Biotherapeutics, Inc. Common Stock (SABS)
SAB Biotherapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 276.57M |
| Beta | 0.67 |
| Earnings Per Share (EPS) | -1.33 |
| Price-to-Book (P/B) Ratio | 1.13 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 1.50% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -6.74% |
| Current Ratio | 7.28% |
| Free Cash Flow | -41.03M |
